Clinical Trial

Comparative Study of Nutraceuticals vs. Conventional Prophylactic Therapy in the Management of Migraine

Not Yet Recruiting Phase 3
View on ClinicalTrials.gov →
Record status
This record was last updated August 29, 2025 (before its estimated February 1, 2026 completion). Its status may not reflect the trial's current state.
Summary
Migraine is a common disabling neurological condition that significantly affects quality of life. While traditional prophylactic treatments (e.g., beta-blockers, antiepileptics) are effective, they may be associated with side effects leading to poor adherence. Recent evidence suggests that nutraceuticals like magnesium, riboflavin, and coenzyme Q10 may provide a safer alternative. This study aims to compare the efficacy and tolerability of these two approaches.
Trial Details
NCT Number NCT07147972
Lead Sponsor Fayoum University
Conditions Migraine, Nutraceuticals
Enrollment 100 participants
Start Date 2025-08-20
Primary Completion 2026-02-01 (estimated)
Study Completion 2026-02-01 (estimated)
Updated on ClinicalTrials.gov 2025-08-29